RxDoctor Payments Data

Timothy Maher, MD

Clinical Cardiac Electrophysiology · Boston, MANPI 1912396607

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $96,663 of the $122,971 with a category attached, or 78.6%. 10 manufacturers reported payments, led by Biosense Webster, Inc. at 56.4% of the total. 2025 is the largest year on record at $66,354, more than ten times the $272 reported in 2019.

$122,971in general payments, 2019–2025

Across 253 payments — averaging $486.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biosense Webster, Inc.$69K
  • Medical Device Business Services, Inc.$27K
  • Abbott$15K
  • Medtronic$8K
  • Biotronik Inc.$3K
  • Boston Scientific$863
  • plus $348 from 4 others
$87,963in research payments, 2019–2025

Across 2 payments — averaging $43,981 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$62K
  • Circa Scientific, Inc.$25K

What the payments were for

  • Consulting fees$96,66379%
  • Speaking & faculty fees$3,1503%
  • Grants$8281%
  • Travel & lodging$10,5959%
  • Food & beverage$10,8579%
  • Education$8781%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$122,971 in reported general payments places this provider in the 85th percentile of 106 clinical cardiac electrophysiology providers in Massachusetts.

See all clinical cardiac electrophysiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$144,829
Medicare patients
515
Services billed
1,019

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban18$22,457
XareltoRivaroxaban14$8,766
Amiodarone Hcl19$508
Metoprolol Succinate11$342

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$75$8,76614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 106 clinical cardiac electrophysiology providers in Massachusetts.

Other clinical cardiac electrophysiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →